Does Phenobarbital IV Contain Propylene Glycol?
Yes, intravenous phenobarbital formulations contain propylene glycol as a solvent. According to the FDA drug label, each mL of Phenobarbital Sodium Injection contains 0.678 mL of propylene glycol (in addition to the active drug, alcohol, and benzyl alcohol) 1.
Propylene Glycol Content and Dosing Implications
The propylene glycol content in phenobarbital IV is substantial:
- Standard formulation: 0.678 mL propylene glycol per mL of phenobarbital solution 1
- Concentration: This represents approximately 67.8% propylene glycol by volume in the formulation
- Clinical significance: When phenobarbital is used at high doses or as continuous infusions (particularly for refractory status epilepticus or intracranial hypertension), patients receive large cumulative doses of propylene glycol
Toxicity Risk and Monitoring
Propylene glycol toxicity is a well-documented complication of high-dose phenobarbital infusions, particularly in vulnerable populations 2, 3. The World Health Organization recommends a maximum of 25 mg/kg of propylene glycol 4.
High-Risk Scenarios:
- Continuous infusions for status epilepticus or intracranial hypertension 3, 5
- Neonates and young children (higher risk due to immature metabolism) 6, 4
- Renal impairment (decreased clearance leads to accumulation) 2, 7
- Prolonged therapy (>48 hours increases risk) 8
Clinical Manifestations of Toxicity:
- High anion gap metabolic acidosis with elevated lactate 2, 3, 5, 4
- Elevated osmolar gap (>10-20 mOsm/kg) 2, 4
- Acute kidney injury with proximal tubular damage 7
- Hemodynamic instability and hypotension 4
- Symptoms mimic sepsis, making diagnosis challenging 2
Essential Monitoring Parameters:
- Osmolar gap (calculated vs measured osmolality) - most sensitive early indicator
- Serum lactate and arterial blood gas for metabolic acidosis
- Anion gap calculation
- Renal function (creatinine, urine output)
- Monitor these parameters at baseline and every 12-24 hours during high-dose or continuous infusions
Management of Propylene Glycol Toxicity
If toxicity develops, immediately reduce or discontinue phenobarbital and initiate renal replacement therapy 3, 5:
- Decrease infusion rate or stop phenobarbital entirely
- Continuous renal replacement therapy (CRRT) or hemodialysis effectively removes propylene glycol and corrects acidosis 3, 5
- Supportive care with fluid resuscitation and hemodynamic support as needed
- Sodium bicarbonate may be used for severe acidosis while arranging dialysis
Special Population Considerations
Neonates:
Phenobarbital IV is NOT recommended in neonates due to the benzyl alcohol preservative (separate toxicity concern causing "gasping syndrome") 1. However, if used, propylene glycol exposure at typical doses (34 mg/kg/24h) appears tolerated for up to 48 hours 8, though long-term safety data are lacking 6.
Patients with Renal Disease:
Exercise extreme caution - end-stage renal disease is a major precipitating factor for propylene glycol accumulation and toxicity 2, 7. Consider alternative anticonvulsants or plan for early dialysis support.
Clinical Pitfall
The most dangerous scenario occurs when clinicians are unaware of propylene glycol content and attribute symptoms (acidosis, hypotension, renal dysfunction) to the underlying condition or sepsis rather than iatrogenic toxicity 2. Maintain high clinical suspicion when using high-dose or prolonged phenobarbital infusions, especially in patients with renal impairment.